Peter Gray

Peter Gray joined the Abzena Board as an Independent Director in 2018, bringing with him over 30 years of experience within the pharmaceutical services industry, including as Chairman of UDG Healthcare plc, as CEO of ICON plc, where previously he had been CFO, and as CFO of Elan Corporation plc.

Peter currently sits on the board of Jazz Pharmaceuticals plc and is chairman of Teckro Inc, a clinical trial enabling technology company. He was previously an Independent Director director at Aptuit LLC and at UDG Healthcare plc.

Peter holds a degree in law from Trinity College Dublin, Ireland and qualified as a chartered accountant in 1981.